BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20566767)

  • 1. In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum.
    Brilhante RS; Fechine MA; Cordeiro Rde A; Rocha MF; Ribeiro JF; Monteiro AJ; de Lima RA; Mesquita JR; de Camargo ZP; Sidrim JJ
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3978-9. PubMed ID: 20566767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum.
    de Aguiar Cordeiro R; de Farias Marques FJ; de Aguiar Cordeiro R; da Silva MR; Donato Maia Malaquias A; Silva de Melo CV; Mafezoli J; Ferreira de Oliveira Mda C; Nogueira Brilhante RS; Gadelha Rocha MF; Pinheiro Gomes Bandeira Tde J; Costa Sidrim JJ
    Antimicrob Agents Chemother; 2014 May; 58(5):2504-11. PubMed ID: 24514090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibitory effect of miltefosine against strains of Histoplasma capsulatum var. capsulatum and Sporothrix spp.
    Brilhante RS; Malaquias AD; Caetano EP; Castelo-Branco Dde S; Lima RA; Marques FJ; Silva NF; Alencar LP; Monteiro AJ; Camargo ZP; Bandeira Tde J; Rodrigues AM; Cordeiro Rde A; Moreira JL; Sidrim JJ; Rocha MF
    Med Mycol; 2014 Apr; 52(3):320-5. PubMed ID: 24662247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Brilhante RS; Caetano EP; Sidrim JJ; Cordeiro RA; Camargo ZP; Fechine MA; Lima RA; Castelo Branco DS; Marques FJ; Mesquita JR; Lima DT; Monteiro AJ; Rocha MF
    Mycoses; 2013 May; 56(3):397-401. PubMed ID: 23205615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
    Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drugs saquinavir and ritonavir reduce inhibitory concentration values of itraconazole against Histoplasma capsulatum strains in vitro.
    Brilhante RS; Caetano ÉP; Riello GB; Guedes GM; Castelo-Branco Dde S; Fechine MA; Oliveira JS; Camargo ZP; Mesquita JR; Monteiro AJ; Cordeiro Rde A; Rocha MF; Sidrim JJ
    Braz J Infect Dis; 2016; 20(2):155-9. PubMed ID: 26748233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.
    Wüst J; Wilkins TD
    Antimicrob Agents Chemother; 1978 Sep; 14(3):384-90. PubMed ID: 708016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
    Cordeiro Rde A; Marques FJ; Brilhante RS; Rocha de Castro E Silva K; Mourão CI; Caetano EP; Fechine MA; Ribeiro JF; Castelo-Branco Dde S; de Lima RA; Mesquita JR; Monteiro AJ; Rocha FA; Rocha MF; Sidrim JJ
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4482-4. PubMed ID: 21690286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Genotypic and Phenotypic Methods for Analyzing the Susceptibility to Sulfamethoxazole and Trimethoprim in Edwardsiella piscicida.
    Kim A; Lim Y; Kim N; Luan Nguyen T; Roh HJ; Park CI; Han HJ; Jung SH; Cho MY; Kim DH; Smith P
    Microb Drug Resist; 2018 Oct; 24(8):1226-1235. PubMed ID: 29437540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitizing activity of the anti-bacterial drugs sulfamethoxazole and trimethoprim.
    Zhou W; Moore DE
    J Photochem Photobiol B; 1997 May; 39(1):63-72. PubMed ID: 9210323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacodynamics and bacteriology in sulfamethoxazole-trimetoprim combination therapy].
    Bergan T
    Tidsskr Nor Laegeforen; 1972 Feb; 92(4):274-7. PubMed ID: 5016492
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the susceptibilities of anaerobic bacteria to trimethoprim and sulfamethoxazole individually and in combination.
    Tosolini FA; Butcher RH
    Clin Ther; 1983; 5(6):629-31. PubMed ID: 6605193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of El Tor and classical Vibrio cholerae strains to trimethoprim and sulfamethoxazole.
    Northrup RS; Doyle MA; Feeley JC
    Antimicrob Agents Chemother; 1972 Apr; 1(4):310-4. PubMed ID: 4670695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae.
    Paisley JW; Washington JA
    Antimicrob Agents Chemother; 1978 Nov; 14(5):656-8. PubMed ID: 365085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital histoplasmosis due to Histoplasma capsulatum var. duboisii: successful treatment with Septrin.
    Ajayi BG; Osuntokun B; Olurin O; Kale OO; Junaid TA
    J Trop Med Hyg; 1986 Aug; 89(4):179-87. PubMed ID: 3491220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.
    Afeltra J; Meis JF; Vitale RG; Mouton JW; Verweij PE;
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2029-31. PubMed ID: 12019133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
    Najjar A; Murray BE
    Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.
    Stevens DA; Vo PT
    Antimicrob Agents Chemother; 1982 May; 21(5):852-4. PubMed ID: 7103462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.